Chief Medical Officer

Executive Assistant To Chief Executive Officer

Mineralys announces new subgroup analyses from Phase 3 Launch-HTN trial

Mineralys Therapeutics Raises $287.5 Million in Upsized Notes Offering

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need

StockWatch: Ionis Scores on Phase III Data for Olezarsen

Senior Vice President, Regulatory Affairs

Mineralys Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing medicines for diseases driven by elevated aldosterone. The Senior Vice President, Regulatory Affairs will lead the global regulatory function, focusing on NDA submissions and regulatory interactions while ensuring compliance with corporate objectives.

Vice President, Human Resources

Senior Director Human Resources

Chief Business Officer

Sign up with Google

Sign in with Google